HEMATOLOGY Hematology is a compendium, with commentaries, of the most important papers published in the field from 1900-1999. (Web site) Hematology is a distinct subspecialty of internal medicine, separate from but overlapping with the subspecialty of medical oncology. (Web site) Hematology is a medical specialty concerned with the study of blood and blood-forming tissues. (Web site) Hematology is a particularly visual science. (Web site) Hematology is a subspecialty of internal medicine. (Web site)

HEMATOLOGISTS

1. Hematologists are doctors who treat blood diseases. (Web site)
2. Hematologists are increasingly engaged in the diagnosis and management of patients with thrombosis. (Web site)
3. Hematologists are physicians and researchers who specialize in blood diseases. (Web site)
4. Hematologists are physicians who have been trained in the diagnosis and treatment of blood diseases. (Web site)

SYMPTOMS

1. Symptoms are clinically present in 10% of patients when an embolus is of appropriate size. (Web site)
2. Symptoms are described above. (Web site)
3. Symptoms are difficulty swallowing both liquids and solids. (Web site)
4. Symptoms are fever, cough, sputum production, dyspnea and hypoxia. (Web site)
5. Symptoms are more noticeable than in chronic phase. (Web site)

THALASSEMIA

1. Thalassemia is a congenital disease; Iran lies on thalassemic region of the world, and the prevalence of thalasemia is 2.3% in Iran. (Web site)
2. Thalassemia is a congenital hemolytic disorder caused by a partial or complete deficiency of - or -globin chain synthesis. (Web site)
3. Thalassemia is a difficult subject to explain, since the condition is not a single disorder but a group of defects with similar clinical effects. (Web site)
4. Thalassemia is a genetic defect that results in production of an abnormally low quantity of given hemoglobin chain or chains. (Web site)
5. Thalassemia is a genetic disease that results in the production of abnormal hemoglobin molecules.

THROMBIN

1. Thrombin is a key effector enzyme in the coagulation cascade. (Web site)
2. Thrombin is a potent stimulus for platelet aggregation and degranulation[14]. (Web site)
3. Thrombin is a serine protease, produced from prothrombin, by the action of an enzyme, prothrombinase, in the final states of coagulation. (Web site)
4. Thrombin is a trypsin-like serine protease. (Web site)
5. Thrombin is also a powerful stimulus for platelet activation and aggregation.

THROMBOEMBOLISM

1. Thromboembolism is a general term describing both thrombosis and its main complication which is embolisation. (Web site)
2. Thromboembolism is a general term describing both thrombosis and its main complication: dislodgement of a clot and embolisation. (Web site)
3. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. (Web site)
4. Thromboembolism is a major cause of morbidity and mortality. (Web site)
5. Thromboembolism is an important cause of morbidity (disease) and mortality (death), especially in adults. (Web site)

THROMBOPHILIA

1. A thrombophilia was found in four of seven multiparous study women (57%) who had had obstetric complications in a previous pregnancy. (Web site)
2. The term "thrombophilia" refers to a tendency to have recurrent venous thromboembolism. (Web site)
3. Thrombophilia is a major cause of morbidity and mortality in PNH. (Web site)
4. Thrombophilia is a term that describes a state in which the blood has an increased tendency to clot. (Web site)
5. Thrombophilia is an increased propensity to form thrombosis in the arterial or venous circulation [1, 2]. (Web site)

THROMBOSIS

1. Thrombosis is a common complication in cancer patients [6 ]. (Web site)
2. Thrombosis is a common complication in patients with cancer and may be the first presentation of occult malignancy. (Web site)
3. Thrombosis is a life-threatening complication of hemolytic anemia in humans. (Web site)
4. Thrombosis is a particular hazard during pregnancy and in the puerperium. (Web site)
5. Thrombosis is a specific medical term for a blood clot that remains in the place where it formed. (Web site)

THROMBOTIC THROMBOCYTOPENIC PURPURA

1. Thrombotic thrombocytopenic purpura is a rare but serious haematological disease for which first-line therapy is medical, but not always successful.
2. Thrombotic thrombocytopenic purpura is a rare disorder that causes blood clots (thrombi) to form in small blood vessels throughout the body. (Web site)
3. Thrombotic thrombocytopenic purpura is a rare hematologic disorder involving the formation of platelet aggregates in the microvasculature.
4. Thrombotic thrombocytopenic purpura is a rare yet serious blood disorder characterized by the formation of small blood clots throughout the body.
5. Thrombotic thrombocytopenic purpura is a syndrome with diverse causes, not all of which have been elucidated. (Web site)

THROMBUS

1. A thrombus is a blood clot that forms in a vein. (Web site)
2. A thrombus is a blood clot that forms in a vessel and remains there.
3. A thrombus is a blood clot that forms inside a blood vessel or cavity of the heart. (Web site)
4. Thrombus: A blood clot in a blood vessel or within the heart. (Web site)

VENOUS THROMBOEMBOLISM

1. The term "venous thromboembolism" is sometimes used when discussing both DVT and PE. (Web site)
2. VENOUS thromboembolism is a common and clinically important complication of major orthopedic surgery. (Web site)
3. Venous thromboembolism is a chronic disease with episodic recurrence; about 30% of patients develop recurrence within the next 10 years. (Web site)
4. Venous thromboembolism is a common condition affecting 7.1 persons per 10 000 person-years among community residents. (Web site)
5. Venous thromboembolism is a common disease that causes significant morbidity and mortality. (Web site)

VENOUS THROMBOSIS

1. A venous thrombosis is a blood clot that forms within a vein. (Web site)
2. Venous thrombosis is a blood clot that develops in the veins. (Web site)
3. Venous thrombosis is a cause of considerable morbidity and mortality. (Web site)
4. Venous thrombosis is a common disease, with an estimated annual incidence of 1 in 1000 persons. (Web site)
5. Venous thrombosis is a common disorder. (Web site)

VON WILLEBRAND FACTOR

1. Von Willebrand factor is a blood glycoprotein involved in coagulation. (Web site)
2. Von Willebrand factor is a blood glycoprotein involved in hemostasis.
3. Von Willebrand factor is a blood glycoprotein of the coagulation system.
4. Von Willebrand factor was purified from pooled normal plasma by precipitation with glycine salts and gel filtration. (Web site)

WARFARIN

1. The warfarin was discontinued and she was begun on maintenance enoxaparin. (Web site)
2. Warfarin is a drug that is given to prevent clots in the deep veins of the legs and to treat pulmonary embolism. (Web site)
3. Warfarin is a racemic mixture of 2 optically active isomers, the R and S forms, in roughly equal proportion. (Web site)
4. Warfarin is also used to reduce the risk of clots causing strokes or heart attacks . (Web site)
5. Warfarin is an anticoagulant that is taken in pill form. (Web site)

ACUTE LYMPHOBLASTIC LEUKEMIA

1. Acute Lymphoblastic Leukemia is a form of cancer which affects the lymphocytes and lymphocyte producing cells in the bone marrow. (Web site)
2. Acute lymphoblastic leukemia is a cancer of the blood and bone marrow.
3. Acute lymphoblastic leukemia is a heterogeneous disease with distinct biologic and prognostic groupings. (Web site)
4. Acute lymphoblastic leukemia is a highly aggressive form of B-cell leukemia. (Web site)
5. Acute lymphoblastic leukemia is the most common leukemia in children, with approximately 3,000 new patients diagnosed each year in the United States. (Web site)

ACUTE MYELOGENOUS LEUKEMIA

1. Acute myelogenous leukemia is a cancer of blood-forming tissues of the bone marrow. (Web site)
2. Acute myelogenous leukemia is a cancer of the blood in which too many granulocytes, a type of white blood cell, are produced in the marrow. (Web site)
3. Acute myelogenous leukemia is a cancer of the blood in which too many immature granulocytes (myeloblasts) are produced in the marrow. (Web site)
4. Acute myelogenous leukemia is a cancer of the blood in which too many myeloblasts, a type of immature white blood cell, are produced in the marrow. (Web site)
5. Acute myelogenous leukemia is a cancer of the blood, which can be caused by chemical exposure. (Web site)

ACUTE PROMYELOCYTIC LEUKEMIA

1. Acute promyelocytic leukemia is a cancer of the blood. (Web site)
2. Acute promyelocytic leukemia is a distinct subtype of AML, accounting for 5% to 15% of cases, with unique clinical, morphologic, and cytogenetic features. (Web site)
3. Acute promyelocytic leukemia is a rare type of AML that prevents blood from clotting normally. (Web site)
4. Acute promyelocytic leukemia is a subtype of acute myeloid leukemia, a cancer of the blood and bone marrow. (Web site)
5. Acute promyelocytic leukemia is a subtype of acute myelogenous leukemia ( AML), a cancer of the blood and bone marrow . (Web site)

AGRANULOCYTOSIS

1. AGRANULOCYTOSIS IS a life-threatening disorder that frequently occurs as an adverse reaction to drugs. (Web site)
2. Agranulocytosis is a condition in which there is an insufficient number of white blood cells called neutrophils or granulocytes. (Web site)
3. Agranulocytosis is a rare and serious disease often caused by drugs. (Web site)
4. Agranulocytosis is the most serious complication of deferiprone therapy and occurs in about 1% of treated patients. (Web site)
5. Agranulocytosis: A marked decrease in the number of granulocytes. (Web site)

ANEMIA OF CHRONIC DISEASE

1. Anemia of chronic disease is a blood disorder that results from a medical condition that affects the production and lifespan of red blood cells. (Web site)
2. Anemia of chronic disease is a diagnosis of exclusion ( 13). (Web site)
3. Anemia of chronic disease is a multifactorial anemia often coexistent with iron deficiency. (Web site)
4. Anemia of chronic disease is the most common normocytic anemia and the second most common form of anemia worldwide (after iron deficiency anemia). (Web site)
5. In many cancer patients, the causative mechanism of anemia is incompletely defined; thus, the term "anemia of chronic disease" is used. (Web site)

ANTICOAGULANT THERAPY

1. Anticoagulant therapy is a unique challenge in patients with acute leukemia, who are at high risk for hemorrhage. (Web site)
2. Anticoagulant therapy is one of the most common forms of medical intervention. (Web site)
3. Anticoagulant therapy is one of the most widely used medical therapies. (Web site)
4. Anticoagulant therapy was entered in the model as a time-dependent covariate. (Web site)

ANTICOAGULATION

1. Anticoagulation is commonly used in patients with PNH who have a history of thrombosis and has been proposed as a prophylaxis for higher risk patients. (Web site)
2. Anticoagulation is the main therapy for acute DVT of the leg. (Web site)
3. Anticoagulation is the mainstay of therapy for VTE in children. (Web site)
4. Anticoagulation is the only relevant treatment in DVT. Thrombolysis is generally reserved for serious pulmonary embolism.
5. Anticoagulation is the usual treatment for DVT. Thrombolysis is generally reserved for extensive clot, e.g. (Web site)

ANTIPHOSPHOLIPID SYNDROME

1. Antiphospholipid Syndrome is a disorder in which the blood clotting system begins to form blood clots in the veins or arteries without obvious reason. (Web site)
2. Antiphospholipid syndrome is a disorder of coagulation, and causes thrombosis in both arteries and veins. (Web site)
3. Antiphospholipid syndrome is a systemic prothrombotic state promoted by diverse, often coexisting antibodies. (Web site)
4. Antiphospholipid syndrome is a well-recognized cause of recurrent miscarriage. (Web site)
5. Antiphospholipid syndrome is also called phospholipid antibody syndrome. (Web site)

ANTITHROMBIN

1. Antithrombin is a serine protease inhibitor ( serpin) that degrades the serine proteases; thrombin and FXa, as well as FXIIa, and FIXa. (Web site)
2. Antithrombin is a serine protease inhibitor ( serpin) that degrades the serine proteases; thrombin and FXa, as well as FXIIa, and FXIa. (Web site)
3. Antithrombin is a serine protease inhibitor ( serpin) that degrades the serine proteases; thrombin, FIXa, FXa, FXIa and FXIIa. (Web site)
4. Antithrombin is a serine protease inhibitor and the main inhibitor of thrombin and factor Xa. (Web site)
5. Antithrombin is a small molecule that inactivates several enzymes of the coagulation system. (Web site)

APHERESIS

1. Apheresis is a method of collecting large numbers of certain blood cells, such as white cells, stem cells, or platelets. (Web site)
2. Apheresis is a method used to collect only a specific part of the donor---s blood.
3. Apheresis is a special kind of blood donation that allows a donor to give specific blood components, such as plasma or platelets. (Web site)
4. Apheresis is a special kind of blood donation. (Web site)
5. Apheresis is a very special type of blood donation. (Web site)

APLASTIC ANEMIA

1. Aplastic Anemia is a condition where one or more types of cells in the bone marrow stop growing and dividing. (Web site)
2. Aplastic Anemia is an illness in which the bone marrow does not produce enough blood cells. (Web site)
3. Aplastic Anemia: An injury to the bone marrow; specifically the stem cells. (Web site)
4. Aplastic anemia is a bone marrow failure syndrome characterized by peripheral pancytopenia and marrow hypoplasia. (Web site)
5. Aplastic anemia is a condition resulting from the failure of the bone marrow called aplasia to produce red blood cells. (Web site)

ARGATROBAN

1. Argatroban is a clear, colorless to pale yellow, slightly viscous solution. (Web site)
2. Argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site. (Web site)
3. Argatroban is a direct thrombin inhibitor that safely augments the benefit of rtPA in animal stroke models. (Web site)
4. Argatroban is a potent synthetic inhibitor of thrombin that is an arginine derivative.
5. Argatroban is a small (molecular weight, 526.6 Da) synthetic peptide derived from L -arginine. (Web site)

AUER RODS

1. Auer rods are classically seen in myeloid blasts of M1, M2, M3, and M4 acute leukemias. (Web site)
2. Auer rods are clumps of azurophilic granular material that form elongated needles seen in the cytoplasm of leukemic blasts. (Web site)
3. Auer rods are clumps of azurophilic granular material. (Web site)
4. Auer rods are defined by classical cytochemical stainings. (Web site)
5. Auer rods are distinctive azurophilic structures resulting from the coalescence of primary granules. (Web site)

BLOOD CELLS

1. Blood cells are degraded by the spleen and the Kupffer cell s in the liver. (Web site)
2. Blood cells are degraded by the spleen and the Kupffer cells in the liver. (Web site)
3. Blood cells are made in the bone marrow of adults. (Web site)
4. Blood cells are made in the bone marrow. (Web site)
5. Blood cells are made up of two components. (Web site)

BLOOD FLOW

1. Blood Flow is a healing spell available to the Bear Shaman class. (Web site)
2. Blood flow is a dynamic process that is affected by many factors and this book looks in detail at how these factors affect any particular Doppler waveform. (Web site)
3. Blood flow is a key modulator of thrombus propagation. (Web site)
4. Blood flow is one of the most important modulators of thrombus formation and propagation. (Web site)
5. Blood flow is the flow of blood in the cardiovascular system. (Web site)

BLOOD TRANSFUSION

1. A blood transfusion is a life-saving medical procedure ordered by your doctor. (Web site)
2. A blood transfusion is a safe, common procedure in which blood is given to you through an intravenous (IV) line in one of your blood vessels. (Web site)
3. A blood transfusion is a way of giving one person's blood to another person who needs it. (Web site)
4. Blood Transfusion - the process of transferring blood or blood-based products from one person into the circulatory system of another. (Web site)
5. Blood transfusion is a medical treatment to replace blood or portions of the blood lost through injury, surgery, or disease. (Web site)

BONE MARROW SUPPRESSION

1. Bone Marrow Suppression: a decrease in the number of blood cells produced; it may be a result of cancer treatment or tumor invasion of bone marrow. (Web site)
2. Bone marrow suppression is a common side effect of chemotherapy treatment. (Web site)
3. Bone marrow suppression is a concern in all animals. (Web site)
4. Bone marrow suppression is a serious adverse effect of piperacillin, which should be kept in mind while treating patients with this drug. (Web site)
5. Bone marrow suppression is a serious side effect of chemotherapy and certain drugs affecting the immune system such as azathioprine. (Web site)

BONE MARROW TRANSPLANT

1. A bone marrow transplant is a form of systemic treatment of invasive breast cancer. (Web site)
2. A bone marrow transplant is a physically, emotionally, and psychologically taxing procedure for both the patient and family. (Web site)
3. A bone marrow transplant is a powerful treatment that offers options for patients with many different diseases. (Web site)
4. A bone marrow transplant is a procedure in which healthy stem cells from a donor's bone marrow are injected into a recipient's vein. (Web site)
5. A bone marrow transplant is a procedure in which normal bone marrow cells are infused into a person. (Web site)

CHRONIC LYMPHOCYTIC LEUKEMIA

1. Chronic Lymphocytic Leukemia is a hematological cancer that affects approximately 60,000 people in the United States. (Web site)
2. Chronic Lymphocytic Leukemia is a malignancy (cancer) of excessive lymphocyte (a type of white blood cell) production. (Web site)
3. Chronic lymphocytic Leukemia is a cancer of the white blood-cell-producing line in the bone marrow where lymphocytes originate.
4. Chronic lymphocytic leukemia is a blood and bone marrow cancer that affects 10,000 new patients each year in the United States. (Web site)
5. Chronic lymphocytic leukemia is a disease in which mature lymphocytes become cancerous and gradually replace normal cells in lymph nodes. (Web site)

CHRONIC MYELOGENOUS LEUKEMIA

1. Chronic Myelogenous Leukemia is a slowly progressing disease in which too many white blood cells (not lymphocytes) are made in the bone marrow. (Web site)
2. Chronic myelogenous leukemia is a cancer of the blood and bone marrow characterized by overproduction of white blood cells. (Web site)
3. Chronic myelogenous leukemia is a disease in which the bone marrow makes too many white blood cells. (Web site)
4. Chronic myelogenous leukemia is a disease in which too many white blood cells are made in the bone marrow . (Web site)
5. Chronic myelogenous leukemia is a disease of the pluripotent stem cell that involves the myeloid and, to a varying degree, the lymphoid compartment. (Web site)

COAGULATION

1. Coagulation is a Halo 2 multiplayer map. (Web site)
2. Coagulation is a complex process by which blood forms clots. (Web site)
3. Coagulation is a complex process by which blood forms solid clots. (Web site)
4. Coagulation is a continuous process which has been subdivided in to pathways for our better understanding only. (Web site)
5. Coagulation is a remake of the Halo: Combat Evolved multiplayer map Blood Gulch. (Web site)

COAGULOPATHY

1. Coagulopathy is a common complication of hemorrhagic shock. (Web site)
2. Coagulopathy is a medical term for a defect in the bodies mechanism for blood clotting. (Web site)
3. Coagulopathy is a medical term for a defect in the body's mechanism for blood clotting. (Web site)
4. Coagulopathy was treated at the physician's discretion. (Web site)
5. Coagulopathy was treated with fresh-frozen plasma or fibrinogen. (Web site)

COOMBS TEST

1. A Coombs test is used to detect the presence of antibodies against the RBC and is usually positive in immune mediated haemolysis. (Web site)
2. A coombs test is used to detect the presence of antibodies against the RBC and is usually positive. (Web site)
3. Coombs test was negative. (Web site)
4. The Coombs Test is used to detect the presence of agglutinated red blood cells in a patient's blood. (Web site)
5. The Coombs test is a test for antibody binding to red blood cells. (Web site)

CRYOPRECIPITATE

1. Cryoprecipitate is a blood product manufactured by warming fresh frozen plasma. (Web site)
2. Cryoprecipitate is a blood product manufactured by warming frozen plasma. (Web site)
3. Cryoprecipitate is a blood product prepared from plasma. (Web site)
4. Cryoprecipitate is a blood product rich in factor VIII, vWF and fibrinogen that is commonly used in various bleeding diatheses. (Web site)
5. Cryoprecipitate is a blood product that contains all clotting factors, so it can be used to treat many varieties of bleeding disorders. (Web site)

CYTOPENIA

1. Cytopenia is a reduction in the number of blood cells. (Web site)
2. Cytopenia is a reduction in the number of cell s circulating in the blood. (Web site)
3. Cytopenia is a reduction in the number of cells circulating in the blood. (Web site)
4. Cytopenia is a reduction in the number of cellscirculating in the blood .

D-DIMER

1. D-Dimer is a blood test relating to breakdown products of a blood clot. (Web site)
2. D-Dimer is a global indicator of coagulation activation and fibrinolysis. (Web site)
3. D-dimer is a blood test performed in the medical laboratory to diagnose thrombosis. (Web site)
4. D-dimer is a blood test performed in the medical laboratory to diagnose. (Web site)
5. D-dimer is a breakdown product of the protein fibrin, which is found in blood clots. (Web site)

DEEP VEIN THROMBOSIS

1. Deep Vein Thrombosis - also known as deep-venous thrombosis or DVT, is the formation of a blood clot (" thrombus ") in a deep vein. (Web site)
2. Deep vein thrombosis is a common but difficult to detect illness that can be fatal if not treated effectively. (Web site)
3. Deep vein thrombosis is a common condition that often presents a diagnostic challenge to clinicians. (Web site)
4. Deep vein thrombosis is a condition in which a blood clot (thrombus) forms in one or more of the deep veins in your body, usually in your legs. (Web site)
5. Deep vein thrombosis is a condition where blood clots develop in the deep veins of your legs. (Web site)

DISSEMINATED INTRAVASCULAR COAGULATION

1. Disseminated Intravascular Coagulation was present in 8 of 31 patients. (Web site)
2. Disseminated intravascular coagulation is a clinical diagnosis. (Web site)
3. Disseminated intravascular coagulation is a clinical syndrome, and laboratory tests provide confirmation. (Web site)
4. Disseminated intravascular coagulation is a complication of underlying illness occurring in approximately one percent of hospital admissions [ 1] . (Web site)
5. Disseminated intravascular coagulation is a frequent complication of sepsis. (Web site)

EOSINOPHILIA

1. Eosinophilia - A brief definition of this disorder and eosinophils. (Web site)
2. Eosinophilia is the state of having high eosinophil granulocyte s in the blood. (Web site)
3. Eosinophilia is the state of having high eosinophil granulocytes in the blood. (Web site)
4. Eosinophilia: An abnormally high number of eosinophils in the blood. (Web site)

ESSENTIAL THROMBOCYTOSIS

1. Essential thrombocytosis is a chronic myeloproliferative disorder. (Web site)
2. Essential thrombocytosis is a disorder characterized by a markedly increased platelet count. (Web site)
3. Essential thrombocytosis is a disorder of the hematopoietic stem cell that causes proliferation of platelets. (Web site)
4. Essential thrombocytosis is a rare illness. (Web site)
5. Essential thrombocytosis is a rare myeloproliferative disorder. (Web site)

EVANS SYNDROME

1. Evans Syndrome is an autoimmune disease involving two primary diseases: autoimmune hemolytic anemia and idiopathic thrombolytic purpura (ITP). (Web site)
2. Evans syndrome is a combination of idiopathic thrombocytopenia and autoimmune hemolytic anemia. (Web site)
3. Evans syndrome is a rare disease defined as autoimmune hemolytic anemia plus immune thrombocytopenia. (Web site)
4. Evans syndrome: a report on 12 patients. (Web site)

FACTOR V LEIDEN

1. Factor V Leiden is a blood disorder that is genetic.
2. Factor V Leiden is a common gene mutation, which results in a genetic predisposition to thromboembolic complications. (Web site)
3. Factor V Leiden is a common genetic mutation that leads to increased risk of blood clots and is associated with pregnancy complications. (Web site)
4. Factor V Leiden is a common thrombophilic mutation. (Web site)
5. Factor V Leiden is a completely different inherited disorder in which factor V is mutated in a specific gene, leading to hypercoagulable status. (Web site)

FERROPORTIN

1. Ferroportin is a Hepcidin binding protein expressed in duodenal enterocytes. (Web site)
2. Ferroportin is a basolateral transporter involved in the release of iron from cells.
3. Ferroportin is a highly conserved 571-amino acid protein with human, mouse, and rat clones being 90–95% homologous at the protein level. (Web site)
4. Ferroportin is a key cellular iron transporter that is downregulated by hepcidin binding. (Web site)
5. Ferroportin is a multi-transmembrane glycoprotein that mediates iron export from cells. (Web site)

FETAL HEMOGLOBIN

1. Fetal hemoglobin is a form of hemoglobin that all humans produce before birth, but most stop making shortly after birth. (Web site)
2. Fetal hemoglobin is a form of hemoglobin that all humans produce before birth, but most stop producing it after birth. (Web site)
3. Fetal hemoglobin is a kind of hemoglobin produced mainly before birth. (Web site)
4. Fetal hemoglobin is a normally occurring hemoglobin that usually decreases from over 90% of the total hemoglobin to under 1% during the first year of life. (Web site)
5. Fetal hemoglobin was measured as a percent of total hemoglobin, normalized to total protein by alkaline denaturation as published previously. (Web site)

FILGRASTIM

1. Filgrastim is a biologic response modifier. (Web site)
2. Filgrastim is a drug that helps your body move more white blood cells out of your bone marrow and into your bloodstream. (Web site)
3. Filgrastim is a human granculocyte colony stimulating factor (G-CSF), produced by recombinant DNA technology. (Web site)
4. Filgrastim is used to treat neutropenia (a low number of neutrophils), stimulating the bone marrow to increase production of neutrophils. (Web site)
5. Filgrastim was administered for a median of 13 days and placebo for a median of 20 days. (Web site)

FLOW CYTOMETRY

1. Flow Cytometry is a quantitative analytical method that can measure physical and chemical properties of cells and particles.
2. Flow Cytometry is a technique by which individual blood or marrow cells can be analyzed for clonality. (Web site)
3. Flow Cytometry is used to obtain an Absolute Lymphocyte Count (ALC) of white blood cells, lymphocytes and T cells. (Web site)
4. Flow cytometry is a blood test that can identify white blood cells that are missing GPI-anchored proteins. (Web site)
5. Flow cytometry is a means of reaching a diagnosis in many cases in hematopathology.
6. Books about "HEMATOLOGY" in Amazon.com